2-196902700-C-T
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_024989.4(PGAP1):c.692G>A(p.Arg231Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000794 in 1,611,944 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_024989.4 missense
Scores
Clinical Significance
Conservation
Publications
- intellectual disability, autosomal recessive 42Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
- autosomal recessive non-syndromic intellectual disabilityInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- autosomal recessive spastic paraplegia type 67Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_024989.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PGAP1 | NM_024989.4 | MANE Select | c.692G>A | p.Arg231Gln | missense | Exon 5 of 27 | NP_079265.2 | ||
| PGAP1 | NM_001321099.2 | c.170G>A | p.Arg57Gln | missense | Exon 6 of 28 | NP_001308028.1 | |||
| PGAP1 | NM_001321100.2 | c.-420G>A | 5_prime_UTR | Exon 5 of 26 | NP_001308029.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PGAP1 | ENST00000354764.9 | TSL:1 MANE Select | c.692G>A | p.Arg231Gln | missense | Exon 5 of 27 | ENSP00000346809.3 | ||
| PGAP1 | ENST00000423035.5 | TSL:1 | n.*623G>A | non_coding_transcript_exon | Exon 6 of 28 | ENSP00000415405.1 | |||
| PGAP1 | ENST00000485830.1 | TSL:1 | n.836G>A | non_coding_transcript_exon | Exon 6 of 10 |
Frequencies
GnomAD3 genomes AF: 0.0000789 AC: 12AN: 152048Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000838 AC: 21AN: 250734 AF XY: 0.0000664 show subpopulations
GnomAD4 exome AF: 0.0000795 AC: 116AN: 1459896Hom.: 0 Cov.: 30 AF XY: 0.0000702 AC XY: 51AN XY: 726360 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000789 AC: 12AN: 152048Hom.: 0 Cov.: 32 AF XY: 0.0000539 AC XY: 4AN XY: 74254 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1
Intellectual disability, autosomal recessive 42 Uncertain:1
This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 231 of the PGAP1 protein (p.Arg231Gln). This variant is present in population databases (rs368553507, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with PGAP1-related conditions. ClinVar contains an entry for this variant (Variation ID: 436296). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The glutamine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at